Expression of hypoxia inducible factor 1 α and Von Hippel Lindau protein in human middle ear cholesteatoma

被引:14
作者
Adunka, O [1 ]
Gstoettner, W [1 ]
Knecht, R [1 ]
Kierner, AC [1 ]
机构
[1] Univ Frankfurt Klinikum, Dept Otorhinolaryngol, D-60590 Frankfurt, Germany
关键词
cholesteatoma; hypoxia inducible factor 1; Von Hippel Lindau protein;
D O I
10.1097/00005537-200307000-00018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective: To evaluate the role of hypoxia in cholesteatoma progression. Study Design: Immunohistochemical analysis of paraffin-embedded human specimens. Methods: Thirteen middle ear cholesteatomas and 10 samples of normal human external ear canal skin were stained immunohistochemically for the presence of hypoxia inducible factor 1 alpha (HIF 1 alpha) and Von Hippel Lindau. protein. Specimens were then analyzed semiquantitatively. Results: Staining for both antibodies could be detected in all cholesteatomas (perimatrix and matrix), as well as in the samples of normal human ear canal skin. Cholesteatoma specimens showed statistically significant increased staining when compared with normal human skin and mucosa. The age of patients and relapse surgery affected immunohistochemical staining of HIF 1 alpha and Von Hippel Lindau protein. Conclusions: Elevated staining intensities for HIF 1 alpha and Von Hippel Lindau protein in cholesteatoma tissue indicated that cholesteatoma may be bypoxic. In addition, our data indicated that relapse cholesteatomas yield a higher degree of hypoxia than ears without surgery.
引用
收藏
页码:1210 / 1215
页数:6
相关论文
共 28 条
  • [1] Localization of matrix metalloproteinase 1 in cholesteatoma and deep meatal skin
    Banerjee, AR
    Jones, JL
    Birchall, JP
    Powe, DG
    [J]. OTOLOGY & NEUROTOLOGY, 2001, 22 (05) : 579 - 581
  • [2] Cycline-dependent kinase inhibitor, p27 (KIP1), is associated with cholesteatoma
    Bayazít, YA
    Karakök, M
    Uçak, R
    Kanlíkama, M
    [J]. LARYNGOSCOPE, 2001, 111 (06) : 1037 - 1041
  • [3] Bezold, 1890, Z OHRENHEILKD, V20, P5
  • [4] Identification of proliferating keratinocytes in middle ear cholesteatoma using the monoclonal antibody Ki-67
    Bujia, J
    Holly, A
    Sudhoff, H
    AntoliCandela, F
    Tapia, MG
    Kastenbauer, E
    [J]. ORL-JOURNAL FOR OTO-RHINO-LARYNGOLOGY AND ITS RELATED SPECIALTIES, 1996, 58 (01): : 23 - 26
  • [5] BUJIA J, 1993, LARYNGOSCOPE, V103, P326
  • [6] Detection of macrophage migration inhibitory factor (MIF) in human cholesteatomas and functional implications of correlations to recurrence status and to expression of matrix metalloproteinases-3/9, retinoic acid receptor-β, and anti-apoptotic galectin-3
    Choufani, G
    Ghanooni, R
    Decaestecker, C
    Delbrouck, K
    Simon, P
    Schüring, MP
    Zick, Y
    Hassid, S
    Gabius, HJ
    Kiss, R
    [J]. LARYNGOSCOPE, 2001, 111 (09) : 1656 - 1662
  • [7] Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
    Cockman, ME
    Masson, N
    Mole, DR
    Jaakkola, P
    Chang, GW
    Clifford, SC
    Maher, ER
    Pugh, CW
    Ratcliffe, PJ
    Maxwell, PH
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) : 25733 - 25741
  • [8] Habermann J, 1888, ARCH OHRENHEILKD, V27, P43
  • [9] Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma
    Hansen, T
    Unger, RE
    Gaumann, A
    Hundorf, I
    Maurer, J
    Kirkpatrick, CJ
    Kriegsmann, J
    [J]. MODERN PATHOLOGY, 2001, 14 (12) : 1226 - 1231
  • [10] Cholesteatoma in children
    Hildmann, H
    Sudhoff, H
    [J]. INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 1999, 49 : S81 - S86